BioNTech and Pfizer said on Wednesday a three-shot course of their Covid-19 vaccine was able to neutralize the new Omicron variant in a laboratory test and they could deliver an Omicron-based vaccine in March 2022 if needed.
AMWAJ Real Estate
BioNTech and Pfizer said on Wednesday a three-shot course of their Covid-19 vaccine was able to neutralize the new Omicron variant in a laboratory test and they could deliver an Omicron-based vaccine in March 2022 if needed.